The United States Patent and Trademark Office (USPTO) has processed a renewal for the trademark DECISIONDX-MELANOMA, identified by application number TM87024849. This renewal pertains to services including medical diagnostic testing for diagnostic and prognostic purposes, as well as the provision of medical information. The renewal is officially effective as of March 20, 2026.

This action represents a routine administrative update for an existing trademark. No new regulatory obligations or compliance requirements are imposed on regulated entities by this trademark renewal. The original filing date for this trademark was May 4, 2016.